Update on Phase IIb study of bomedemstat in essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 2:24 2 years ago 780 Далее Скачать
Updates from a Phase II study of bomedemstat for the treatment of essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 1 004 Далее Скачать
Exciting updates in essential thrombocythemia: exploring novel agents VJHemOnc – Video Journal of Hematology & HemOnc 1:25 1 year ago 1 262 Далее Скачать
Bomedemstat normalizes platelet count for essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 1:47 3 years ago 1 365 Далее Скачать
A Phase II study of the LSD1 inhibitor bomedemstat in patients with polycythemia vera VJHemOnc – Video Journal of Hematology & HemOnc 0:46 6 months ago 225 Далее Скачать
Results of Phase II study of bomedemstat in myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 5:40 2 years ago 252 Далее Скачать
Phase II Study of Ruxolitinib: Essential Thrombocythemia(ET) Refractory to/Intolerant of Hydroxyurea Oncology.TV 4:07 9 years ago 172 Далее Скачать
Phase II trial of bomedemstat for advanced myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 7:42 3 years ago 138 Далее Скачать
Unmet needs and therapeutic strategies in essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 3:29 2 years ago 717 Далее Скачать
Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa The Patient Story 13:08 2 years ago 16 094 Далее Скачать
Bomedemstat in JAK inhibitor-resistant myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 7:10 3 years ago 223 Далее Скачать
Phase II study update of TL-895 in patients with myelofibrosis with severe thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 2:59 1 year ago 89 Далее Скачать
New MPN clinical trials & drugs in 2021 VJHemOnc – Video Journal of Hematology & HemOnc 3:16 3 years ago 257 Далее Скачать
Mechanism of action of bomedemstat VJHemOnc – Video Journal of Hematology & HemOnc 1:49 3 years ago 344 Далее Скачать
Agents of interest being explored in essential thrombocythemia and polycythemia vera VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 252 Далее Скачать
Bomedemstat combined with ruxolitinib for the treatment of MF: early results of a Phase II trial VJHemOnc – Video Journal of Hematology & HemOnc 2:41 10 months ago 609 Далее Скачать
Essential Thrombocythemia: Unmet Needs and a Potential New Treatment with Bomedemstat from Imago Imago BioSciences 1:32 3 years ago 299 Далее Скачать
SURPASS ET: ropeginterferon versus anagrelide as second line therapy in essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 1:59 2 years ago 1 169 Далее Скачать
Upcoming agents in ET and PV VJHemOnc – Video Journal of Hematology & HemOnc 1:39 2 years ago 387 Далее Скачать
SURPASS ET: ropeginterferon alfa-2b vs anagrelide for second-line essential thrombocythemia VJHemOnc – Video Journal of Hematology & HemOnc 1:28 1 year ago 254 Далее Скачать
